Stock Taper Adjusted Net Investment Income (NII): $0.32 per share, matching the dividend paid.
Dividend: $0.32 per share declared for Q1 2026, payable March 31, 2026.
Net Asset Value (NAV): Decreased to $11.52 per share from $12.06, a decline of 4.5%.
Total Investment Income: $77 million, down 4% from the previous quarter.
Total Liabilities: $1.7 billion, with a net debt-to-equity ratio of 1.21:1, expected to decrease to approximately 0.9x post-asset sale.
Portfolio Composition: 95% of the loan portfolio rated green, with no red-rated positions.
Asset Sale: Announced a $477 million sale of several hard-to-value assets, expected to close in March 2026, at 94% of December 31 marks. This sale aims to diversify the portfolio and reduce PIK income.
Performance Fee Reduction: Commitment to reduce the performance fee from 20% to 15% until the end of 2026, and a permanent reduction thereafter.
Portfolio Management: Focus on reducing concentration in top positions and increasing diversification, with top 5 positions now representing 14% of portfolio value, down from 25.6%.
PIK Income: Expected to decrease by 20-25% as proceeds from the asset sale are redeployed into first lien assets.
Dividend Outlook: Anticipated sustainable dividend rate of approximately $0.25 per share per quarter starting Q2 2026.
Market Positioning: Management remains optimistic about future credit investments, particularly in high-quality software loans, and plans to deploy proceeds from the asset sale effectively.
Growth Potential: Potential for equity appreciation in companies like UniTek and continued focus on lending at higher spreads.
Declining NAV: The drop in NAV primarily attributed to lower valuations of Edmentum and Affordable Care, with Edmentum's common equity valuation reduced to $5 million.
Operating Underperformance: Affordable Care is expected to restructure due to ongoing challenges and a highly leveraged capital structure.
Market Volatility: AI-induced market volatility may impact M&A activity and overall market conditions for direct lending.
Non-Accruals: While non-accruals remain low at 1.4% of the portfolio, there are concerns regarding the performance of specific investments.
Asset Sale Process: The asset sale was competitive, with multiple bidders, and focused on reducing PIK income and concentration in top positions.
Pricing Validity: The sale price was viewed as fair, validating internal asset marks despite a slight discount, reflecting market conditions.
Future Strategy: Management emphasized that the sale allows for better portfolio composition and the opportunity to buy back undervalued stock, maintaining a target leverage ratio between 1.0 and 1.25. Overall, NMFC's Q4 2025 earnings call highlighted a strategic shift towards improving portfolio quality and addressing market challenges while maintaining a commitment to shareholder returns through dividends and share buybacks.
SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT